查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908201

药物输送装置市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测（2026-2033 年）

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

药物输送装置市场概览

全球药物输送设备市场预计到 2025 年将达到 4,638 亿美元，到 2033 年将达到 8,414 亿美元。

预计从2026年到2033年，该市场将以7.8%的复合年增长率成长。先进技术在精准药物输送方面的日益普及正在推动市场扩张。

2024年6月，Aptar Digital Health与SHL Medical达成合作，旨在透过将Aptar的SaMD平台与SHL的互联药物输送解决方案（包括Molly Connected Cap）整合，提升注射治疗体验。此次合作旨在透过数位健康创新改善自行注射疗法。这些设备将优化互联药物传输设备市场，最大限度地减少剂量和副作用，从而降低活性成分的使用量并降低成本。此外，由于市场需求不断成长，新型药物输送设备的研发预计将加速进行。

药物传递装置用于治疗气喘、慢性阻塞性肺病（COPD）、糖尿病、癌症、心血管疾病和慢性疼痛等疾病。这些装置可确保药物精准靶向输送，从而提高疗效和患者依从性，同时最大限度地减少副作用。根据美国气喘和过敏基金会（AAFA）统计，美国有超过2700万人患有气喘，约占总人口的十二分之一。超过2,200万18岁以上的成年人患有气喘，女性盛行率（10.8%）高于男性（6.5%）。气喘是美国最常见且治疗费用最高的疾病之一。例如，根据澳洲国家气喘委员会有限公司的说法，于2024年4月1日纳入药品福利计画（PBS）的Sulflumix Easyhaler，含有两种剂量的Fluticasone propionate/Salmeterol：250/50和500/50，用于治疗气喘和慢性阻塞性肺病（COPD）。这种干粉吸入器使用前必须摇匀，并附有剂量计数器。 EasyHaler适用于各种年龄层和疾病严重程度的患者。此外，它还实现了完全的碳中和。

随着老龄化社会的加剧，用于诊断和治疗各种慢性疾病的皮下给药装置的需求日益增长。研究表明，由于老龄化导致的免疫功能下降，65岁及以上人群患心臟病、气喘、呼吸道感染疾病、慢性阻塞性肺病（COPD）和糖尿病等严重的风险增加，这推动了皮下给药装置市场的发展。

目录

第一章调查方法和范围

第二章执行摘要

3. 药物传输装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 药物输送装置市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 药物输送装置市场：产品、估算与趋势分析

  • 药物输送装置市场：按产品分類的差异分析
  • 药物输送装置市场：产品展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 吸入器
  • 注射装置
  • 植入
  • 局部给药系统
  • 口服给药系统
  • 眼科管理系统
  • 喷雾器
  • 经皮吸收贴片
  • 点滴帮浦

第五章 药物输送装置市场：按应用分類的估算与趋势分析

  • 药物输送装置市场：按应用分類的差异分析
  • 药物输送装置市场：应用前景
  • 市场规模、预测与趋势分析（2021-2033）
  • 肿瘤学
  • 感染疾病
  • 呼吸系统疾病
  • 糖尿病
  • 循环系统疾病
  • 自体免疫疾病
  • 中枢神经系统疾病
  • 其他的

6. 药物输送装置市场：最终用途、预测与趋势分析

  • 药物输送装置市场：依最终用途分類的差异分析
  • 药物输送装置市场：终端用户展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 医院
  • 诊断中心
  • 门诊手术中心/诊所
  • 居家医疗环境
  • 其他的

7. 药物输送装置市场：区域、预测与趋势分析

  • 区域仪錶板
  • 区域药物输送装置市场波动分析
  • 药物输送装置市场：分销通路、最终用途、地区、预测与趋势分析
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Gerresheimer AG
    • WL Gore & Associates, Inc.
    • Abbott
    • Terumo Medical Corporation
    • Stryker
    • Medtronic
    • Boston Scientific Corporation
    • Novartis AG
    • Becton, Dickinson and Company
    • Teleflex Incorporated
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Summary

The global drug delivery devices market size was valued at USD 463.8 billion in 2025 and is projected to reach USD 841.4 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The growing adoption of advanced technology for precise drug delivery is driving market expansion.

In June 2024, Aptar Digital Health and SHL Medical partnered to enhance injectable therapy experiences by integrating Aptar's SaMD platform with SHL's connected drug delivery solutions, including the Molly Connected Cap. This collaboration aims to improve self-injection therapy through digital health innovations. These devices optimize the connected drug delivery devices market, minimizing dosage and side effects, which lowers costs by reducing active pharmaceutical ingredient use. The novel drug delivery devices market is also anticipated to witness accelerated R&D efforts owing to rising demand.

Drug delivery devices are used for conditions such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, cancer, cardiovascular diseases, and chronic pain. These devices ensure precise, targeted delivery of medications, improving efficacy and patient compliance while minimizing side effects. According to the Asthma and Allergy Foundation of America, Asthma affects over 27 million people in the U.S., roughly 1 in 12 individuals. Among adults aged 18 and older, over 22 million have asthma, with a higher prevalence in females (10.8%) compared to males (6.5%). Asthma ranks among the most common and expensive diseases in the U.S. For instance, according to National Asthma Council Australia Ltd, the Salflumix Easyhaler, added to the Pharmaceutical Benefits Scheme (PBS) on April 1, 2024, treats asthma and COPD with fluticasone propionate/salmeterol in two strengths: 250/50 and 500/50. It is a dry powder inhaler that requires shaking before use and has a dose counter. The Easyhaler is suitable for various ages and disease severities. In addition, it is entirely carbon neutral.

The rising elderly population has heightened the need for subcutaneous devices for diagnosing and treating various chronic health conditions. Studies indicate that individuals aged 65 and older face increased risks of serious ailments such as heart disease, asthma, respiratory infections, COPD, diabetes, and other disorders, as aging weakens the immune system, thus driving the subcutaneous drug delivery devices market.

Global Drug Delivery Devices Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug delivery devices market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Inhalers
    • Metered-dose inhalers (MDIs)
    • Dry powder inhalers (DPIs)
    • Others
  • Injection Devices
    • Prefilled Syringes
    • Auto-injectors
    • Pen injectors
    • Needle-free injectors
    • Wearable injectors
  • Implants
    • Contraceptive implants
    • Drug-eluting stents
    • Biodegradable implants
  • Topical Delivery System
    • Creams
    • Gels
    • Ointments
  • Oral Delivery System
    • Controlled-release tablets and capsules
    • Buccal and sublingual tablets
  • Occular Delivery System
  • Nebulizers
  • Transdermal Patches
  • Infusion Pumps
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1 Segment Definitions
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for novel drug delivery devices
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancement in drug delivery devices
      • 3.2.1.4. Growing strategic alliances for drug delivery devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with various routes of drug delivery devices
  • 3.3. Drug Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Drug Delivery Devices Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Inhalers
    • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Metered-dose inhalers (MDIs)
        • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Dry powder inhalers (DPIs)
        • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Injection Devices
    • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.1. Prefilled Syringes
        • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.2. Auto-injectors
        • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.3. Pen Injectors
        • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.4. Needle-free Injectors
        • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.5. Wearable Injectors
        • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Implants
    • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.1. Contraceptive Implants
        • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.2. Drug-eluting Stents
        • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.3. Biodegradable Implants
        • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Topical Delivery System
    • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.8.1.1. Creams
        • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.8.1.2. Gels
        • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.8.1.3. Ointments
        • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Oral Delivery System
    • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.9.1.1. Controlled-release Tablets and Capsules
        • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.9.1.2. Buccal and Sublingual Tablets
        • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Occular Delivery System
    • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Nebulizers
    • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Transdermal Patches
    • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Infusion Pumps
    • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Drug Delivery Devices Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Respiratory Diseases
    • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Diabetes
    • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Cardiovascular Diseases
    • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Central Nervous System Disorders
    • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Others
    • 5.12.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Drug Delivery Devices Market: End-use Movement Analysis
  • 6.3. Drug Delivery Devices Market by End-use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory Surgery Centers/Clinics
    • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Home Care Settings
    • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Drug Delivery Devices Market Movement Analysis
  • 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Gerresheimer AG
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. W. L. Gore & Associates, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Terumo Medical Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Stryker
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Boston Scientific Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Becton, Dickinson and Company
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Teleflex Incorporated
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America drug delivery devices market, by country, 2021 - 2033 (USD Billion)
  • Table 4 North America drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 5 North America drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 6 North America drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 7 US drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 8 US drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 9 US drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 10 Canada drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 11 Canada drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 12 Canada drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 13 Mexico drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 14 Mexico drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 15 Mexico drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 16 Europe drug delivery devices market, by region, 2021 - 2033 (USD Billion)
  • Table 17 Europe drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 18 Europe drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 19 Europe drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 20 Germany drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 21 Germany drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 22 Germany drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 23 UK drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 24 UK drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 25 UK drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 26 France drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 27 France drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 28 France drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 29 Italy drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 30 Italy drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 31 Italy drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 32 Spain drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 33 Spain drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 34 Spain drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 35 Denmark drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 36 Denmark drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 37 Denmark drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 38 Sweden drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 39 Sweden drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 40 Sweden drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 41 Norway drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 42 Norway drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 43 Norway drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 44 APAC drug delivery devices market, by region, 2021 - 2033 (USD Billion)
  • Table 45 APAC drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 46 APAC drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 47 APAC drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 48 China drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 49 China drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 50 China drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 51 Japan drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 52 Japan drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 53 Japan drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 54 India drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 55 India drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 56 India drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 57 Thailand drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 58 Thailand drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 59 Thailand drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 60 South Korea drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 61 South Korea drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 62 South Korea drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 63 Australia drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 64 Australia drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 65 Australia drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 66 Latin America drug delivery devices market, by region, 2021 - 2033 (USD Billion)
  • Table 67 Latin America drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 68 Latin America drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 69 Latin America drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 70 Brazil drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 71 Brazil drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 72 Brazil drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 73 Argentina drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 74 Argentina drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 75 Argentina drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 76 Middle East and Africa drug delivery devices market, by region, 2021 - 2033 (USD Billion)
  • Table 77 Middle East and Africa drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 78 Middle East and Africa drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 79 Middle East and Africa drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 80 South Africa drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 81 South Africa drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 82 South Africa drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 83 Saudi Arabia drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 84 Saudi Arabia drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 85 Saudi Arabia drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 86 UAE drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 87 UAE drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 88 UAE drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
  • Table 89 Kuwait drug delivery devices market, by product, 2021 - 2033 (USD Billion)
  • Table 90 Kuwait drug delivery devices market, by application, 2021 - 2033 (USD Billion)
  • Table 91 Kuwait drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Drug delivery devices market, Product outlook key takeaways (USD Million)
  • Fig. 12 Drug delivery devices market Product movement analysis 2025 & 2033 (USD Million)
  • Fig. 13 Inhalers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Injection devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Prefilled syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Auto-injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Pen injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Needle-free injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Wearable injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Contraceptive implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Drug-eluting stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Biodegradable implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Topical delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Creams market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Gels market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Ointments market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Oral delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Occular delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Nebulizers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Transdermal patches market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Infusion pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Drug delivery devices market, application outlook key takeaways (USD Million)
  • Fig. 39 Drug delivery devices market application movement analysis 2025 & 2033 (USD Million)
  • Fig. 40 Oncology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Infectious diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Respiratory diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Cardiovascular diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Autoimmune diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Central nervous system disorders market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Drug delivery devices market, end use outlook key takeaways (USD Million)
  • Fig. 49 Drug delivery devices market, end use movement analysis 2025 & 2033 (USD Million)
  • Fig. 50 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Diagnostic centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Million)
  • Fig. 53 Home care settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Drug delivery devices market: Regional key takeaways (USD Million)
  • Fig. 56 Drug delivery devices market regional outlook, 2025 & 2033, USD Million
  • Fig. 57 North America drug delivery devices estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 US drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Canada drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Europe drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UK drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Germany drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 France drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Spain drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Italy drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Sweden drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Norway drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Denmark drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 China drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Japan drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 India drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Australia drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Argentina drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 UAE drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Kuwait drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 List of key emerging company's/distribution channel disruptors/innovators